Clinical Trial Update: Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing micafungin to fluconazole for esophageal candidiasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Candidiasis

Drugs mentioned

• Diflucan (Fluconazole)
• Mycamine (Micafungin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Candidiasis, Oral | Phase 3 | Status: COMPLETED